Medtronic receives Breakthrough Device designation from FDA
September 09, 2020 – Medtronic plc (Dublin, OH) announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of the Intrepid…
Medtronic plc
Medtronic receives FDA approval for Minimed 770g insulin pump system with smartphone connectivity
September 1, 2020 – Medtronic plc (Dublin, Ireland) received U.S. Food and Drug Administration (FDA) approval of its MiniMed 770G hybrid closed loop system. The…
Medtronic Board appoints new director
August 24, 2020 – Medtronic plc (Dublin, Ireland) announced that its Board of Directors appointed Kevin Lofton to the Board as an independent director, effective…
Medtronic Evolut TAVR system receives updated U.S. labeling revising precaution for treatment of low-risk patients with bicuspid aortic stenosis
August 21, 2020 – Medtronic plc (Dublin, Ireland) announced that the U.S. Food and Drug Administration (FDA) has approved revised commercial labeling for the Evolut…
Medtronic to acquire Companion Medical, a smart insulin pen company
August 11, 2020 – Medtronic plc (Dublin, Ireland) announced the planned acquisition of privately-held Companion Medical, manufacturer of InPen — the only U.S. FDA-cleared smart…
Medtronic receives FDA approval for two new products: InterStim Micro Neurostimulator, InterStim SureScan MRI leads
August 03, 2020 – Medtronic plc (Dublin, Ireland) received approval from the U.S. Food and Drug Administration (FDA) for its InterStim Micro neurostimulator and InterStim…
Medtronic receives FDA clearance for LINQ II Insertable Cardiac Monitor (ICM)
Medtronic receives FDA clearance for LINQ II Insertable Cardiac Monitor (ICM)